Unlocking the Microbial key to theFuture of humanHealth
SMALLMICROBES.MIGHTYINNOVATIONS.
Our Process
4.Launch
MADEFOREVERYSTAGEOFTHEHEALTHJOURNEY
WeAREONAMISSIONTOrapidlyinnovateanddeliverbreakthroughsolutionsforunmetmedicalneeds.
Pipeline
Launched
SBD111
Clinically validated to slow bone loss via the targeting of osteoclastic activity (clinical study pending publication & peer review)
Toggle for Pipeline
DiscoveryDevelopmentPreclinical TestingClinicalLaunch
July 2025
SBD121
Being developed to address the needs of rheumatoid arthritis
Toggle for Pipeline
DiscoveryDevelopmentPreclinical TestingClinicalLaunch
December 2025
SBDXXX
Being developed to address the needs of psoriatic arthritis
Toggle for Pipeline
DiscoveryDevelopmentPreclinical TestingClinicalLaunch
JUNE 2026
SBDXXX
Being developed to address the needs of cellular aging
Toggle for Pipeline
DiscoveryDevelopmentPreclinical TestingClinicalLaunch